Stephen L.  Silvestro net worth and biography

Stephen Silvestro Biography and Net Worth

Insider of OptimizeRx

Steve Silvestro brings more than 20 years of experience in direct operations, sales, and partner network growth, to lead revenue activities and strengthen the go-to-market.

Steve is responsible for driving OptimizeRx's platform revenue growth including enterprise-level direct-to-patient and direct-to-provider product adoption to improve patient outcomes.

During his tenure at Decision Resources Group, he was an instrumental leader in the growth of the company from $30 million to $180 million in revenue. His customer-first philosophy is greatly aligned to our values at OptimizeRx.  

Steve previously served as vice president and general manager at CCH Tagetik, a division of Wolters Kluwer. Prior pharma leadership experience includes executive positions with Prognos, Decision Resources Group, and D.M.S. Silvestro has extensive channel expertise in biopharma commercialization, global market access, market research, analytics, enterprise SaaS solutions, and strategy.  

Silvestro received a master’s degree in Business Management from Harvard University. He also holds undergraduate degrees from Brigham Young University in both Business and Italian. He is fluent in English, Italian, Spanish and conversational in French. 

What is Stephen L. Silvestro's net worth?

The estimated net worth of Stephen L. Silvestro is at least $29,312.00 as of August 16th, 2022. Mr. Silvestro owns 3,200 shares of OptimizeRx stock worth more than $29,312 as of April 24th. This net worth evaluation does not reflect any other assets that Mr. Silvestro may own. Additionally, Mr. Silvestro receives a salary of $458,600.00 as Insider at OptimizeRx. Learn More about Stephen L. Silvestro's net worth.

How old is Stephen L. Silvestro?

Mr. Silvestro is currently 46 years old. There are 6 older executives and no younger executives at OptimizeRx. The oldest executive at OptimizeRx is Mr. Todd Inman, Chief Technology Officer, who is 68 years old. Learn More on Stephen L. Silvestro's age.

What is Stephen L. Silvestro's salary?

As the Insider of OptimizeRx Co., Mr. Silvestro earns $458,600.00 per year. There are 2 executives that earn more than Mr. Silvestro. The highest earning executive at OptimizeRx is Mr. William J. Febbo, CEO & Director, who commands a salary of $694,400.00 per year. Learn More on Stephen L. Silvestro's salary.

How do I contact Stephen L. Silvestro?

The corporate mailing address for Mr. Silvestro and other OptimizeRx executives is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. OptimizeRx can also be reached via phone at (248) 651-6568 and via email at [email protected]. Learn More on Stephen L. Silvestro's contact information.

Has Stephen L. Silvestro been buying or selling shares of OptimizeRx?

Stephen L. Silvestro has not been actively trading shares of OptimizeRx in the last ninety days. Learn More on Stephen L. Silvestro's trading history.

Who are OptimizeRx's active insiders?

OptimizeRx's insider roster includes Douglas Baker (CFO), William Febbo (CEO), Miriam Paramore (Insider), Stephen Silvestro (Insider), and Patrick Spangler (Director). Learn More on OptimizeRx's active insiders.

Are insiders buying or selling shares of OptimizeRx?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 4,000 shares worth more than $60,760.00. The most recent insider tranaction occured on January, 9th when General Counsel Marion Odence-Ford sold 4,000 shares worth more than $60,760.00. Insiders at OptimizeRx own 4.4% of the company. Learn More about insider trades at OptimizeRx.

Information on this page was last updated on 1/9/2024.

Stephen L. Silvestro Insider Trading History at OptimizeRx

See Full Table

Stephen L. Silvestro Buying and Selling Activity at OptimizeRx

This chart shows Stephen L. Silvestro's buying and selling at OptimizeRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

OptimizeRx Company Overview

OptimizeRx logo
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.
Read More

Today's Range

Now: $9.16
Low: $8.73
High: $9.17

50 Day Range

MA: $12.87
Low: $8.94
High: $16.17

2 Week Range

Now: $9.16
Low: $6.92
High: $16.65

Volume

144,354 shs

Average Volume

123,480 shs

Market Capitalization

$166.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98